BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22132113)

  • 1. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.
    Kim SN; Doo AR; Park JY; Bae H; Chae Y; Shim I; Lee H; Moon W; Lee H; Park HJ
    PLoS One; 2011; 6(11):e27566. PubMed ID: 22132113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice.
    Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T
    Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
    Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
    Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
    Xu X; Song N; Wang R; Jiang H; Xie J
    Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
    Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
    Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ analysis of acupuncture protecting dopaminergic neurons from lipid peroxidative damage in mice of Parkinson's disease.
    Zuo T; Xie M; Yan M; Zhang Z; Tian T; Zhu Y; Wang L; Sun Y
    Cell Prolif; 2022 Apr; 55(4):e13213. PubMed ID: 35274781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease.
    Yun HM; Choi DY; Oh KW; Hong JT
    Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
    J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease.
    Balke D; Tatenhorst L; Dambeck V; Ribas VT; Vahsen BF; Michel U; Bähr M; Lingor P
    Mol Neurobiol; 2020 Feb; 57(2):685-697. PubMed ID: 31446549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
    Crocker SJ; Smith PD; Jackson-Lewis V; Lamba WR; Hayley SP; Grimm E; Callaghan SM; Slack RS; Melloni E; Przedborski S; Robertson GS; Anisman H; Merali Z; Park DS
    J Neurosci; 2003 May; 23(10):4081-91. PubMed ID: 12764095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease.
    Kim YM; Choi SY; Hwang O; Lee JY
    Mol Neurobiol; 2022 Nov; 59(11):6956-6970. PubMed ID: 36057709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease.
    Kim SN; Kim ST; Doo AR; Park JY; Moon W; Chae Y; Yin CS; Lee H; Park HJ
    Int J Neurosci; 2011 Oct; 121(10):562-9. PubMed ID: 21770712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.
    Rosa AI; Duarte-Silva S; Silva-Fernandes A; Nunes MJ; Carvalho AN; Rodrigues E; Gama MJ; Rodrigues CMP; Maciel P; Castro-Caldas M
    Mol Neurobiol; 2018 Dec; 55(12):9139-9155. PubMed ID: 29651747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.